ArticleBritish journal of cancer2010

Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction.

L Stingl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.